HomeTagsIDEAYA

IDEAYA

Healthcare

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated...

PR Newswire - April 24, 2023

IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...

Biotechnology

IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK

PR Newswire - September 1, 2022

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has...

E2open Appoints Pawan Joshi as CSO & Rachit Lohani as CPTO

Rocket Lab Delivers Second, Completes Third for Varda

aiMotive and Safran Unite for Safer ADAS & AD Development

Mauro Atalla Named Trane Technologies CTO & Sustainability Officer

IDEAYA

Hot Topics

E2open Appoints Pawan Joshi as CSO & Rachit Lohani as CPTO

Rocket Lab Delivers Second, Completes Third for Varda

aiMotive and Safran Unite for Safer ADAS & AD Development